<DOC>
	<DOCNO>NCT01716598</DOCNO>
	<brief_summary>Targeted Lung Denervation ( TLD ) Therapy safe method ablate airway nerve trunk travel parallel outside main bronchus lung achieve target lung denervation potentially improve breathing quality life patient suffer COPD . Use IPS System technically feasible access target treatment location deliver RF energy target treatment location .</brief_summary>
	<brief_title>Evaluation IPS System TLD Therapy Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>FEV1 30 % 60 % Patient diagnose COPD Positive relative change FEV1 great 15 % Patient 40 year age old time consent Smoking history least 10 pack year Nonsmoking minimum 6 month prior consent agrees continue smoke duration study Documented history current evidence pulmonary hypertension Documented history current evidence polycythemia level great Documented history current evidence congestive heart failure Patient SaO2 less equal 88 % PaO2 le equal 7.3 kPa ( 55 mm Hg ) room air Patient PaCO2 &gt; 8.0 kPa ( 60 mm Hg ) Prior lung transplant , LVRS , LVR , median sternotomy , bullectomy lobectomy Pulmonary nodule require surgery History recurrent respiratory infection ( 3 hospitalization within 1 year enrollment ) Presence pacemaker , internal defibrillator implantable electronic device j . Active respiratory infection within past 4 week k. COPD exacerbation within past 4 week l. Myocardial infarction ( MI ) within last 6 month m. Unstable life threaten arrhythmia within last year n. Malignancy treat radiation chemotherapy within last 2 year o. Documented history respiratory disease ( cystic fibrosis , tuberculosis , vocal chord dysfunction , ChurgStrauss syndrome , allergic bronchopulmonary aspergillosis )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>TLD Therapy</keyword>
	<keyword>Targeted Lung Denervation Therapy</keyword>
	<keyword>IPS</keyword>
	<keyword>Innovative Pulmonary Solutions , Inc .</keyword>
	<keyword>Holaira , Inc .</keyword>
</DOC>